The clonal evolution of metastatic colorectal cancer

Tumor heterogeneity and evolution drive treatment resistance in metastatic colorectal cancer (mCRC). Patient-derived xenografts (PDXs) can model mCRC biology; however, their ability to accurately mimic human tumor heterogeneity is unclear. Current genomic studies in mCRC have limited scope and lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Ha X., Krasnick, Bradley A., White, Brian S., Grossman, Julie G., Strand, Matthew S., Zhang, Jin, Cabanski, Christopher R., Miller, Christopher A., Fulton, Robert S., Goedegebuure, S. Peter, Fronick, Catrina C., Griffith, Malachi, Larson, David E., Goetz, Brian D., Walker, Jason R., Hawkins, William G., Strasberg, Steven M., Linehan, David C., Lim, Kian H., Lockhart, A. Craig, Mardis, Elaine R., Wilson, Richard K., Ley, Timothy J., Maher, Christopher A., Fields, Ryan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286679/
https://www.ncbi.nlm.nih.gov/pubmed/32577507
http://dx.doi.org/10.1126/sciadv.aay9691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286679/
https://www.ncbi.nlm.nih.gov/pubmed/32577507
http://dx.doi.org/10.1126/sciadv.aay9691

Ejemplares similares